Literature DB >> 31479145

Association of Sodium-Glucose Cotransporter 2 Inhibitor Treatment With Risk of Hospitalization for Fournier Gangrene Among Men.

Chintan V Dave1, Sebastian Schneeweiss1, Elisabetta Patorno1.   

Abstract

Entities:  

Year:  2019        PMID： 31479145      PMCID： PMC6724526          DOI： 10.1001/jamainternmed.2019.2813

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

1.  Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.

Authors:  Chintan V Dave; Seoyoung C Kim; Allison B Goldfine; Robert J Glynn; Angela Tong; Elisabetta Patorno
Journal:  Circulation       Date:  2020-12-11       Impact factor: 29.690

Review 2.  Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies.

Authors:  Thomas M Caparrotta; Andrew M Greenhalgh; Karen Osinski; Robert M Gifford; Svenja Moser; Sarah H Wild; Rebecca M Reynolds; David J Webb; Helen M Colhoun
Journal:  Diabetes Ther       Date:  2021-03-04       Impact factor: 2.945

Review 3.  Preventing all-cause hospitalizations in type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A narrative review and proposed clinical approach.

Authors:  Meir Schechter; Matan Fischer; Ofri Mosenzon
Journal:  Diabetes Obes Metab       Date:  2022-03-24       Impact factor: 6.408

4.  Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials.

Authors:  Shrita Patel; Anne Hickman; Robert Frederich; Susan Johnson; Susan Huyck; James P Mancuso; Ira Gantz; Steven G Terra
Journal:  Diabetes Ther       Date:  2020-05-05       Impact factor: 2.945

5.  SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Authors:  Katherine R Tuttle; Frank C Brosius; Matthew A Cavender; Paola Fioretto; Kevin J Fowler; Hiddo J L Heerspink; Tom Manley; Darren K McGuire; Mark E Molitch; Amy K Mottl; Leigh Perreault; Sylvia E Rosas; Peter Rossing; Laura Sola; Volker Vallon; Christoph Wanner; Vlado Perkovic
Journal:  Diabetes       Date:  2020-10-26       Impact factor: 9.461
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.